Healthcare -
Biotechnology - NASDAQ - US
$ 1.875
-3.85 %
$ 393 M
Market Cap
-1.21
P/E
ALLO - OTHER LONG-TERM ASSETS
Other Long-term Assets ALLO - Allogene Therapeutics, Inc.
16.9 M
LAST VALUE
43.26%
2 YEAR CAGR
61.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR